Skip to main content
. 2020 Dec 16;26(2):e230–e240. doi: 10.1002/onco.13581
Number of Patients, Male 0
Number of Patients, Female 28
Stage II A — 5
II B — 12
III A — 7
III B — 1
III C — 3
Age Median: 48 years
Number of Prior Systemic Therapies Median: 0
Performance Status: ECOG

0 — 27

1 — 1

2 —

3 —

Unknown —

Other
Receptor status ER/PR‐postive — 15
ER positive/PR negative — 4
ER neg/PR positive — 1
ER/PR negative — 8
Nuclear grade Grade 1 — 3
Grade 2 — 10
Grade 3 — 15